# MPC-004 for the Treatment of an Acute Gout Flare

> **NCT00506883** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 185 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** High Dose Colchicine (4.8 mg total dose)
- **DRUG:** Low Dose Colchicine (1.8mg total dose)
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT00506883
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506883, "MPC-004 for the Treatment of an Acute Gout Flare". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00506883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*